Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Payables (2017 - 2025)

Historic Payables for Bioceres Crop Solutions (BIOX) over the last 9 years, with Q3 2025 value amounting to $85.1 million.

  • Bioceres Crop Solutions' Payables fell 2974.49% to $85.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.1 million, marking a year-over-year decrease of 2974.49%. This contributed to the annual value of $216.2 million for FY2025, which is 2923.89% down from last year.
  • According to the latest figures from Q3 2025, Bioceres Crop Solutions' Payables is $85.1 million, which was down 2974.49% from $216.2 million recorded in Q2 2025.
  • Bioceres Crop Solutions' Payables' 5-year high stood at $305.5 million during Q2 2024, with a 5-year trough of $66.7 million in Q3 2021.
  • For the 5-year period, Bioceres Crop Solutions' Payables averaged around $134.7 million, with its median value being $113.5 million (2023).
  • Its Payables has fluctuated over the past 5 years, first surged by 3334.89% in 2022, then plummeted by 3293.29% in 2025.
  • Bioceres Crop Solutions' Payables (Quarter) stood at $93.4 million in 2021, then rose by 12.92% to $105.5 million in 2022, then grew by 7.58% to $113.5 million in 2023, then increased by 5.01% to $119.2 million in 2024, then fell by 28.57% to $85.1 million in 2025.
  • Its last three reported values are $85.1 million in Q3 2025, $216.2 million for Q2 2025, and $95.6 million during Q1 2025.